L a u r e l Wa t e r s M D F C A P FA S C P
5 Dolores Court Moraga, CA 94556
Phone (925) 457-3664 Fax (925) 377-0543
lwatersmd@yahoo.com
Board Certification
 American Board of Pathology–Pediatric Pathology, August 1999
 American Board of Nuclear Medicine, September 1986
 American Board of Pathology–Anatomic and Clinical Pathology, June 1984
Licensure
 California License G46277
Post Graduate Medical Training
 Pediatric Pathology Fellowship. State University of New York, Downstate-Brooklyn. 1999
 Nuclear Medicine. University of California at Davis/Martinez Veterans Administration Medical
Center. Martinez, CA. 1984–1986
 Anatomic & Clinical Pathology. University of California at Davis/Martinez Veterans
Administration Medical Center. Martinez, CA 1980–1984
 Pediatric Internship. University of California. San Francisco, CA. 1979–1980
 Pediatric Gastroenterology Research Fellowship. University of California. San Francisco, CA.
1978–1979
Education
 MD. University of California at Davis. 1978
 BS. University of California at Berkeley, 1974. Double Major: Nutrition and Food Science;
Biochemistry
Experience
Founder, PerinatalPath, Moraga, CA. 2000–Present:
 Medical Legal Consultant and Expert Witness (plaintiff and defendant) issues including:
 uterine rupture; abruption; intrapartum demise; cerebral palsy; birth asphyxia; chronic
hypoxia; infection; birth injury; stillbirth; prematurity; hypoxic ischemic encephalopathy;
pediatric poisoning, injuries, wrongful death, meconium aspiration syndrome; adult
pathology including pulmonary embolism and subdural hematoma
 Analysis of poor perinatal outcome (Help parents understand the process)
 Autopsies, placental pathology; re-examination of placenta and autopsy slides
 Lectures: eg. Perinatal Grand Rounds on Stillbirth Etiologies
 Berkeley Public Health, Maternity & Child Health Consultant; Substance Abuse Task force and
Low Birth Weight Prevention Team
 Fetal and Infant Mortality Review teams Contra Costa, Alameda, Sonoma, Kern Counties.
Hold locums 2000-Present
Positions in Anatomic (Surgical & Cytopathology) and Clinical Pathology including:
Pathlab, Tauranga, New Zealand
MendocinoCoastHospital,Fort Bragg, CA
Contra Costa Medical Center, Martinez, CA
SW Washington MC, Vancouver, WA
Pathology Services, Sebastapol, CA
Doctors Hospital, San Pablo, CA.
Kaiser Santa Teresa, San Jose, CA
Premier Pathology; Porterville, CA
Sutter Santa Rosa Medical Center, CA
Laboratory Director: California Medical Facility, Vacaville, CA 1997-2001: Oversaw quality control
in clinical laboratory. Conducted quality assurance on surgical pathology specimens sent out. Performed and
read bone marrows. Provided in-service training on quality control procedures and other topics for laboratory
technologists.
Assistant Laboratory Director: Pediatric, Anatomic and Clinical Pathology, Children’s Hospital.
Oakland, Oakland, CA 1995–2000:
Supervised clinical and anatomic laboratory. Handled children’s tumor specimens giving primary diagnoses and
preparing specimens for multiple special studies including cytogenetics. Read flow cytometry. Read unusual
hematology smears of malignancies and infectious diseases. Interfaced with clinical physicians regarding
laboratory tests, results, and specimens. Lectured to hematology oncology fellows and staff physicians.
Resolved blood bank problems including transfusion reaction work-ups and antibody identification. Served as
member of Quality Assurance Committee that ensured appropriate procedures following deaths.
Associate Pathology and Nuclear Medicine Physician: St. Luke’s Hospital, San Francisco, CA
1992–1994: Served as assistant director of medium-sized hospital clinical laboratory also performing anatomic
pathology: frozen sections, surgicals, autopsy, and cytology. Directed blood bank. Developed Concurrent Blood
Usage Program with immediate physician feedback and education, which received praise from Joint
Commission for the Accreditation of Hospitals (JCAHO). Oversaw quality control processes for the lab:
hematology, microbiology, chemistry. Interfaced with physicians. Read Nuclear Medicine scans. Honored with
invitation to serve on overall hospital Quality Assurance Committee.
Laboratory Director: Joint Venture between Damon Clinical Laboratories and Mt. Zion Medical
Center/University of California, San Francisco, San Francisco, CA 1991–1992
Co-directed several laboratories including Damon satellite facility in Stockton, East Bay Hospital in Richmond
and multi physician group laboratories in the Central Valley. Chaired Blood Utilization Committee and sat on
Patient Care Committee with all other chairs. Oversaw quality control and quality assurance, managed physician
questions, and set up new Damon College of American Pathologists (CAP) certified stand-alone laboratory in
Pleasanton, CA.
Associate Pathologist. NorthBay Medical Center, Fairfield, CA 1989–1991
Directed mid-size medical laboratory. Established quality control system for blood glucose testing. Worked with
nurse managers to ensure their understanding of system. Introduced state-of-the-art breast tumor marker testing.
Medical Director: Meris Laboratories, San Jose, CA 1988–1989
Directed operations of regional reference laboratory. Prepared lab for first CAP inspection, working with
supervisors of five lab sections to meet CAP standards. Supervised upgrade of procedure manuals.
Associate Pathology and Nuclear Medicine Physician: Marshal Hale Memorial Hospital., San
Francisco, CA 1986–1988
Chaired Infection Control Committee as it introduced Universal Pathogen Precautions and when it merged with
Children’s Hospital. Chaired Tissue Committee. Served on Utilization Review Committee.
Medical Organization Affiliations
 Fellow, College of American Pathologists
 American Medical Women’s Association
National Treasurer 2010-2012
National Board of Directors 2008-2010
 Fellow, American Society of Clinical Pathology
 Society for Pediatric Pathology
Bylaws Committee
 California Society of Pathology
 South Bay Pathology Society
 Oregon Pathology Association
Presentations and Publications include:
 Workup of Stillbirths. Washington Hospital. Fremont, CA 2010
 Consultation with a Pediatric Pathologist in Cases of Poor Perinatal Outcome: Stillbirth
Perinatal Grand Rounds. Good Samaritan Hospital. San Jose, CA. 2009
 ASCO-CAP Guidelines on Breast Cancer: the Effects of Fixation Times on Prognostic
Markers. Multi-hospital Breast Tumor Board. Santa Rosa, CA. 2007
 Placental Infections and Inflammation. Presentation. El Camino Hospital. Mountain View,
CA. 2006
 Placental Pathology. Presentation. Washington Hospital. Fremont, CA. 2005
 Placenta Previa. Presentation. Valley Medical Center. Pleasanton, CA 2005
 Placental Pathology. Presentation. CA Association of Midwives. Occidental, CA 2005
 Placental Pathology: Beyond Apgars. Paper presentation. Medical Women’s International
Association (MWIA). Tokyo. Japan. 2004
 Placental Pathology: Beyond Apgars. Poster presentation. National American Medical
Women’s Association (AMWA) Annual Meeting. San Diego, CA. 2004
 Substance Abuse Effects on Placentas and Fetuses. Lecture. Berkeley Low Birthweight
Prevention Team. Berkeley Public Health Department. Berkeley, CA. 2003
 Hemolytic Disease of the Newborn. Lecture. San Jose SU, Med Tech Program. San Jose, CA.
2003
 Pediatric Renal Tumors other than Wilms. Lecture. Children’s Hospital Oakland
Hematology Oncology Department, Oakland, CA. 2002
 Placental Pathology. Lecture. Ob-Gyn/Pediatric combined department meeting at Doctors
Hospital, San Pablo, CA. 2002
 Clear Cell Sarcoma, Kidney. Case presentation and discussion, South Bay Pathology Society,
Palo Alto, CA. 2002
 Malignant Metanephric Stromal Tumor, Kidney. Case presentation and discussion, South
Bay Pathology Society, Palo Alto, CA. 2001
 Perinatal Loss. National AMWA Meeting. Organized half-day workshop: presentations by
medical geneticist, pediatric pathologist, and social worker. San Francisco, CA. 1999
 Hydrops: Pathogenetic Mechanisms and Differential Diagnosis. Lecture. SUNY Downstate,
Pathology Department, Brooklyn, NY. 1999
 Parvovirus and Fetal Infection. Case presentation and hour lecture. SUNY Downstate,
Pathology Department, Brooklyn, NY. 1999


Mesenchymal Hamartoma Balanced Translocation t(5,19) Implies Pathophysiology as
Neoplasm of Uncertain Malignant Potential, L Waters, P Cotter, R Williams. Poster and
Presentation at Society for Pediatric Pathology, Fall Meeting, Providence, RI. 1999
Massive Hemolysis due to Clostridium perfringens Sepsis: Contaminated Blood Versus
Line or Endogenous Infection, L Waters, C Evans, R Williams. Abstract, poster and
presentation at Society for Pediatric Pathology, Fall Meeting, Providence, RI. 1999
Perinatal & Pediatric Pathology Continuing Medical Education includes:
 Society for Pediatric Pathology: Washington DC 2010
 MedicoLegal Pediatric Issues: USCAP Washington DC 2010
 The Fragmented Fetus: USCAP Washington DC 2010
 Obstetric Malpractice Issues: 2009 Chicago, IL
 Fetal Death: Principles and Pathology: Harvard 2009 Boston, MA
 Society for Pediatric Pathology 2008 Denver, CO Endocrine; Transfusion & Coagulation
 Perinatal Course 2007 Phoenix, AZ
 Society for Pediatric Pathology 2007 Phoenix, AZ
 College of American Pathologists 2007 Pediatric Autopsy and Placental Pathology. Chicago, IL
 Pediatric Forensic Pathology (IPME) 2006 Orlando, FL
 Perinatal Pathology Course:. Society for Pediatric Pathology. Boston, MA. 2005
 Soft Tissue Tumors and Placental Pathology Courses. Pediatric Lung Development
Symposium. Society for Pediatric Pathology, Spring Meeting. Vancouver, BC. 2004
 Placental Pathology Video Microscopy by Dr Geoffrey Machin. California Society of
Pathologists. San Francisco, CA. 2003
 Lysosomal Storage Disease: Therapeutics Symposium. Pediatric Pathology Courses. Society
for Pediatric Pathology, Fall Meeting. Cincinnati, OH. 2003
 Pre-eclampsia. Society for Pediatric Pathology–Perinatal Symposium. Cincinnati, OH. 2003
 Pediatric Tumors. Institute of Pediatric Medical Education. Aspen, CO. 2003
 Pediatric Forensic Pathology. Institute of Pediatric Medical Education. Orlando, FL. 2002
 Biochemical & Molecular Basis of Pediatric Disease Symposium. Society for Pediatric
Pathology, Fall Meeting. Dallas, TX. 2002
 Developmental Biology of the Placenta. SPP Perinatal Symposium. Dallas, TX. 2002
 Perinatal Pathology. Institute of Pediatric Medical Education. Snowmass, CO. 2002
 Placental Pathology course given by Robert Redline. American Society Clinical Pathology
Weekend of Pathology. Santa Monica, CA. 2002
 Congenital Heart Disease. Society for Pediatric Pathology, Spring Meeting. Chicago, IL. 2002
 Pediatric Pathology Symposium. Society for Pediatric Pathology Meeting. Providence, RI.
1999
 Prenatal Screening, Diagnosis and Fetal Therapy. Society for Pediatric Pathology–Perinatal
Symposium. Providence, RI. 1999
 Cystic Renal Disease Symposium. Society for Pediatric Pathology, Spring Meeting. SF 1999
 Pediatric GI Pathology course. US College of American Pathologists. San Francisco, CA. 1999
 Pediatric Tumors, Pediatric Hepatology, and Liver Transplantation, Institute of Pediatric
Medical Education. Aspen, CO. 1998
 Pediatric Pathology, Pediatric Gastroenterology, and Nutrition, Institute of Pediatric Medical
Education. Aspen, CO 1997
General Pathology Continuing Medical Education includes:
 South Bay Pathology Society: monthly CME Palo Alto, CA
 Oregon Pathology Association: quarterly CME Portland, OR
 Borderline Tumors. South Bay Pathology Society Monterey, CA 2011
 Immunohistochemistry. South Bay Pathology Society Monterey, CA 2009
 USCAP Practical Pathology 2009 San Francisco, CA
 USCAP 2008 Denver, CO. Molecular Pathology, GI Pathology, Inflammatory Dermatoses.
 CTTR Dec 2007 San Francisco, CA
 ASCP 2007 Conference in New Orleans, LA
 CAP 2007 Chicago, IL
 OPA 2007 Endometrial Carcinoma & Molecular Studies. Portland, OR
 CAP 2006 Conference. Courses attended included breast pathology, state of the art breast
pathology, and cytology. San Diego, CA. 2006
 Current Issues in Anatomic Pathology. Stanford/UC San Francisco. San Francisco, CA.2011,
2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 1999
 Pathology Business Retreat. Pathology Services Associates. San Antonio, TX 2005
 Bone and Soft Tissue Tumors. South Bay Pathology Society. Monterey, CA. 2005
 Genitourinary Tumors. South Bay Pathology Society. Monterey, CA. 2004
 Molecular, Anatomic and General Lab Inspector Training. College of American Pathology. San
Jose, CA. 2004
 Rational Use of Molecular Studies in Leukemias and Lymphomas, Stem Cell Research and
various courses and lectures. US & Canadian Academy of Pathology. Vancouver BC. 2004
 American Pathology Foundation. Las Vegas, NV. 2004
 Breast Pathology, Liver Pathology VideoMicroscopy and various courses and lectures. California
Society of Pathologists. San Francisco, CA. 2003
 Coagulation Disorders, New Clinical Laboratory Tests, the Pathology of Infectious Diseases and
various courses and lectures. CAP ’03. College of American Pathologists. San Diego, CA. 2003
 American Pathology Foundation. Orlando, FL. 2003
 Malignant Lymphoid Tumors: Hodgkin’s Disease and non-Hodgkin’s Lymphomas WHO
Classification, and Pattern Diagnosis, American Society of Clinical Pathology. Las Vegas, NV.
2003
 Head and Neck Pathology. South Bay Pathology Society. San Francisco, CA. 2003
American Medical Women’s Association Meetings include:
 Annual, Washington DC 2011
 Annual with Women’s Health, Washington DC 2010
 Interim, Philadelphia PA 2009
 Annual with Women’s Health, Williamsburg VA 2009
 Women’s Health Williamsburg VA 2008
 Interim, Philadelphia, PA 2008
 Annual, Anaheim , CA 2008
 Annual, Orlando FL 2007
 Interim, Chicago, IL 2007
 Leadership Retreat, CO 2007
 Annual, Tucson AZ 2006